ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ZINGO
Topical pain relief
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ZINGO Rx

Generic Name and Formulations:
Lidocaine HCl (as monohydrate) 0.5mg/device; pwd for intradermal inj.

Company:
Anesiva, Inc.

Therapeutic Use:

Indications for ZINGO:

To provide local analgesia prior to venipuncture in adults and children or peripheral IV cannulation in children.

Adults and Children:

<3yrs: not established. ≥3yrs: Use only on intact skin. Apply one 0.5mg dose to the planned procedure site 1–3 mins before needle insertion; may repeat once at new site after initial attempt failed. Multiple administrations to same site: not recommended.

Warnings/Precautions:

Avoid eyes, body orifices, mucous membranes or areas with a compromised skin barrier. Severe hepatic disease or pseudocholinesterase deficiency. Bleeding tendencies or platelet disorders: higher risk of superficial dermal bleeding. Labor & delivery. Pregnancy (Cat.B). Nursing mothers.

Interactions:

Additive effects with other local anesthetics.

Pharmacological Class:

Local anesthetic (amide-type).

Adverse Reactions:

Application-site reactions (eg, erythema, petechiae, edema, pruritus), systemic reactions (eg, nausea, vomiting), dizziness.

Generic Availability:

NO

How Supplied:

Single-use device (disposable, needle-free)—12

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs